Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124566422 | 12456642 | 2 | F | 20151227 | 20160809 | 20160610 | 20160815 | EXP | US-BIOGEN-2016BI00167815 | BIOGEN | 62.93 | YR | M | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124566422 | 12456642 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | 125104 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 124566422 | 12456642 | 2 | SS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 3 | SS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 4 | SS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 5 | C | MODAFINIL. | MODAFINIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 6 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 7 | C | MINOXIDIL. | MINOXIDIL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 8 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124566422 | 12456642 | 9 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124566422 | 12456642 | 1 | Multiple sclerosis |
| 124566422 | 12456642 | 5 | Product used for unknown indication |
| 124566422 | 12456642 | 6 | Product used for unknown indication |
| 124566422 | 12456642 | 7 | Product used for unknown indication |
| 124566422 | 12456642 | 8 | Product used for unknown indication |
| 124566422 | 12456642 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124566422 | 12456642 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124566422 | 12456642 | Asthenia | |
| 124566422 | 12456642 | Neurogenic bladder | |
| 124566422 | 12456642 | Urinary tract infection | |
| 124566422 | 12456642 | Ventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124566422 | 12456642 | 1 | 20080314 | 20121212 | 0 | |
| 124566422 | 12456642 | 2 | 20130403 | 20130920 | 0 | |
| 124566422 | 12456642 | 3 | 20140710 | 0 | ||
| 124566422 | 12456642 | 4 | 20080301 | 0 |